Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial

JAMA

Volumn 283, Issue 10, 2000, Pages 1303-1310

  Sees, Karen L ^a   Delucchi, Kevin L ^a   Masson, Carmen ^a   Rosen, Amy ^a   Clark, H Westley ^a   Robillard, Helen ^a   Banys, Peter ^a   Hall, Sharon M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DETOXIFICATION; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY;

EID: 0034052091     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.10.1303     Document Type: Article

References (27)

1. New data shows opiates take lead over cocaine in treatment admission. US Dept of Health and Human Service News [serial online]. August 26. 1999. Available at: htp://www.samhsa.gov/NEWS /DocsShowOnecfm.?newsid=121. Accessed February 9, 2000.
2. Simpson DD, Joe GW, Bracy SA. Six-year follow-up of opioid addicts after admission to treatment. Arch Gen Psychiatry. 1982;39:1318-1323.
3. Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance. J Health Soc Behav. 1998;29:214-226.
4. Kosten TR, Gawin FH, Rousaville BJ. Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse. 1986; 12:1-16.
5. Wasserman DA, Korcha R, Havassy BE, Hall SM. Factors associated with lapses to heroin use during methadone maintenance. Drug Alcohol Depend. 1998; 52:183-192.
6. Simpson DD, Savage LJ, Lloyd MR. Follow-up evaluation of treatment abuse during 1969 to 1972. Arch Gen Psychiatry. 1979;36:772-780.
7. Hubbard RL, Rachal JV, Craddock SG, Cavanaugh ER. Treatmet Outcome Prospective Study (TOPS): Client Characteristics and Behaviors Before, During, and After Treatment. Rockville, Md: National Institute on Drug Abuse; 1984:42-68.
8. McLellan AT, Kuskner AT, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199-213.
9. Resnick R. Methadone detoxification from illicit opiates and methadone maintenance. In: Cooper JR, ed. Research on the Treatment of Narcotic Addiction: State of the Art. Rockville, Md: National Institute on Drug Abuse; 1983:160-171.
10. Mann AR, Feit MD. An analysis of federal narcotic detoxification policy: implications for rehabilitation. Am J Drug Alcohol Abuse. 1982-1983;19:289-299.
11. Sorensen JL, Hargreaves WA, Weinberg JA. Withdrawal from heroin in three or six weeks: comparison of LAAM versus methadone. Arch Gen Psychiatry. 1982;39:167-171.
12. 54 Federal Register 8954 (1989)(codified at 21 CFR §291).
13. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953-1959.
14. Woody GE, Luborsky L, McLellan AT, et al. Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry. 1983;40:25-32.
15. Zanis DA, McLellan AT, Cnaan RA, Randall M. Reliability and validity of the Addiction Severity Index with a homeless sample. J Subst Abuse Treat. 1994; 11:541-548.
16. Robins LN, Heizer JE, Croughan JL, Ratcliff KS. National Institute of Mental Health Diagnosis Interview Schedule: its history, characteristics and validity. Arch Gen Psychiatry. 1981;38:381-389.
17. Burnham M, Karno M, Hough R, Escobar J, Forsythe A. The Spanish Diagnostic Interview Schedule: reliability and comparison with clinical diagnosis. Arch Gen Psychiatry. 1983;40:1189-1196.
18. Erdman HP, Klein MH, Greist JH, et al. A comparison of two computer-administered versions of the NIMH Diagnostic Interview Schedule. J Psychiatr Res. 1992;26:85-95.
19. Levitan RD, Blouin AG, Navarro JR, Hill J. Validity of the computerized DIS for diagnosing psychiatric inpatients. Can J Psychiatry 1991;36: 728-731.
20. Metzger D, Woody G, De Philippis D, McLellan AT, O'Brien CP, Platt JJ. Risk factors for needle sharing among methadone-treatment patients. Am J Psychiatry. 1991;148:636-640.
21. McLellan AT, Alterman Al, Cacciola J, Metzger D, O'Brian CF. A new measure of substance abuse treatment: initial studies of the Treatment Services Review. J Nerv Ment Dis. 1992;180:101-110.
22. Diggle PJ, Liang WR, Myers CP, Friedman SR. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 1994.
23. Maude-Griffin PM, Hohenstein JM, Humfleet GL, Reilly PM, Tusel DJ, Hall SM. Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol. 1998;66:832-837.
24. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Arch Gen Psychiatry. 1994;51:989-997.
25. Crits-Christoph P, Siqueland L, Blaine J, et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse collaborative cocaine treatment study. Arch Gen Psychiatry. 1999;56:493-502.
26. Carroll KM, Rounsaville BJ, Gordon LT, et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry. 1994;51:177-187.
27. Higgins ST, Delaney DD, Budney AJ, et al. A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry. 1991;148:1218-1224.